Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

Rajendran, L., Honsho, M., Zahn, T.R., Keller, P., Geiger, K.D., Verkade, P., Simons, K.
Journal   Proc Natl Acad Sci USA.
Analytes Measured   Abeta 40 , APP
Matrix Tested   Exosome fractions from cell culture medium
Year   2006
Volume   103
Page Numbers   11172-7
Application   Alzheimers
Although the exact etiology of Alzheimer's disease (AD) is a topic of debate, the consensus is that the accumulation of beta-amyloid (Abeta) peptides in the senile plaques is one of the hallmarks of the progression of the disease. The Abeta peptide is formed by the amyloidogenic cleavage of the amyloid precursor protein (APP) by beta- and gamma-secretases. The endocytic system has been implicated in the cleavages leading to the formation of Abeta. However, the identity of the intracellular compartment where the amyloidogenic secretases cleave and the mechanism by which the intracellularly generated Abeta is released into the extracellular milieu are not clear. Here, we show that beta-cleavage occurs in early endosomes followed by routing of Abeta to multivesicular bodies (MVBs) in HeLa and N2a cells. Subsequently, a minute fraction of Abeta peptides can be secreted from the cells in association with exosomes, intraluminal vesicles of MVBs that are released into the extracellular space as a result of fusion of MVBs with the plasma membrane. Exosomal proteins were found to accumulate in the plaques of AD patient brains, suggesting a role in the pathogenesis of AD.

View Publications

Related Products

R-PLEX Aβ40 (4G8) Antibody Set
Aβ40 (4G8) | Human, Mouse, Rat
R-PLEX Human Aβ40 (6E10) Antibody Set
Aβ40 (6E10) | Human
Neurodegeneration Control Pack 1
Aβ38, Aβ40, Aβ42, Tau (total) | Human, Mouse, Rat
sAPPα/sAPPβ Kit
APP | Human
sAPPα Kit
APP | Human
sAPPβ Kit
APP | Human
Browse Our Products

By Analytes
By Applications
Customer Service/Orders

Scientific/Technical Support

Instrument Support

Company Headquarters